Neogenomics (NEO) Acquisitions (2014 - 2025)

Neogenomics' (NEO) quarterly Acquisitions came in at $463000.0 in Q3 2025, down 99.89% on a QoQ basis from $419.4 million in Q2 2021.

Neogenomics (NEO) Acquisitions (2014 - 2025) Analysis & Trends

Neogenomics (NEO) has 4 years of Acquisitions data on file, last reported at $463000.0 in Q3 2025.

Quarterly Acquisitions changed N/A year-over-year to $463000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $463000.0 (changed N/A YoY) and the FY2025 annual result came in at $6.5 million, changed N/A from the prior year.
Acquisitions fell to $463000.0 in Q3 2025, from $419.4 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $419.4 million in Q2 2021 to a low of $463000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	-
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	-
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	-
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	163.00 Mn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	2.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	-
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	-
10	Neogenomics	2.05 Bn	1.90 Bn	91.88 Mn	-

Download Data